In patients with device-detected atrial fibrillation and a high comorbidity burden, oral anticoagulation increases bleeding without a clear reduction in stroke. This is the main finding of a sub-analysis of the NOAH–AFNET 6 trial presented by Dr.
Patients with device-detected atrial fibrillation and multiple comorbidities do not benefit from anticoagulation: StudyIn patients with device-detected atrial fibrillation and a high comorbidity burden, oral anticoagulation increases bleeding without a clear reduction in stroke. This is the main finding of a sub-analysis of the NOAH–AFNET 6 trial presented by Dr.
Edoxaban did not considerably reduce thrombo-embolic events, but increased bleeding and death in this patient group. Older age, diabetes, and kidney disease independently predicted the primary outcome defined as a composite of stroke, systemic embolism, or cardiovascular death. Anticoagulation, age,Prof.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
A simple intervention benefits cancer patients while saving hospitals money, study showsCancer patients who received specialized mental health support as part of their treatment plan were more likely to see improvements in their quality of life and reductions in pain, depression and fatigue, according to a study led by researchers at the University of Pittsburgh School of Medicine.
Read more »
Patients are delaying cancer checks because of difficulties booking GP appointments, damning study...Cancer Research UK warned that the 'worrying' delays could damage the chances of survival. (Stock Image.)
Read more »
Patients are delaying cancer checks because of difficulties booking GP appointments, damning study...Cancer Research UK warned that the 'worrying' delays could damage the chances of survival. (Stock Image.)
Read more »
Simple blood test could spot patients most at risk of dying from heart failure, study suggestsExperts believe measuring levels of neuropeptide Y (NPY) could help predict how heart failure is likely to progress and therefore identify patients at most risk of dying.
Read more »
Antibiotic dosing technology speeds recovery of ICU patients, study findsUniversity of Queensland researchers have used dosing software to accelerate the effects of antibiotics in patients being treated for sepsis in Intensive Care Units.
Read more »
New Study Finds No Brain Injuries Among ‘Havana Syndrome’ PatientsThe U.S. embassy in Havana, Cuba is seen on Jan. 4, 2023.
Read more »